Brief: Pacira Biosciences FY Adjusted EBITDA USD 224 Million Vs. IBES Estimate USD 222 Million
27/02/2025 21:05
Feb 27 (Reuters) - Pacira Biosciences FY adjusted net income USD 157.7 million vs. IBES estimate USD 155.7 million. FY net income USD -100 million
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees